In a mouse model of human papillomavirus (HPV)-associated head and neck cancer, Newton et al. combined anti-PD-1 and anti-CTLA-4 antibodies with RT (2 × 10 Gy). This evidence concerns the gene PDCD1 and head and neck cancer.